CDC research opportunity
Executive Summary
Centers for Diseases Control & Prevention calls for collaborators to enter into a Cooperative Research & Development Agreement to develop, refine and validate "three interrelated technologies: (1) the exchangeable template reaction, a method to assemble synthetic genes; (2) the construction of hepatitis C virus specific 'mosaic' proteins composed of immunodominant antigenic epitopes; and (3) differential HCV diagnostic tests," CDC says in July 6 Federal Register notice. The CRADA partner will be responsible for preparing "all synthetic peptides and oligonucleotides as necessary for each project area" and "monospecific and monoclonal antibodies whenever appropriate," as well as purifying "antigens from recombinant lysates as needed"